CLARITY Extension Study

Clinical trial NCT00641537 · COMPLETED

Trial details

NCT number: NCT00641537
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2008-02-29
Primary completion: 2011-12-31
Enrollment: 867

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.